Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends new contraindication for Velcade (bortezomib) 20 Μάρτιος 2008Press releaseHumanMedicines European Medicines Agency concludes new advice to doctors and patients for Tysabri (natalizumab) needed 20 Μάρτιος 2008Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,17-19 March 2008 20 Μάρτιος 2008Press releaseHuman Bioenvision Ltd withdraws its application for an extension of indication for Evoltra (clofarabine) 19 Μάρτιος 2008Press release Neurochem withdraws its marketing authorisation application for Kiacta (eprodisate disodium) 17 Μάρτιος 2008Press release Committee for medicinal products for veterinary use: Meeting of 11-13 March 2008 14 Μάρτιος 2008Press releaseVeterinary Wyeth Europa Ltd withdraws its marketing authorisation application forPristiqs (desvenlafaxine) 12 Μάρτιος 2008Press release EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines 10 Μάρτιος 2008Press releaseCorporate Actelion withdraws its application for an extension of indication for Zavesca 25 Φεβρουάριος 2008Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008 21 Φεβρουάριος 2008Press releaseHuman 1 … 315 316 317 318 319 Page 319 of 384 320 321 322 323 … 384
European Medicines Agency recommends new contraindication for Velcade (bortezomib) 20 Μάρτιος 2008Press releaseHumanMedicines
European Medicines Agency concludes new advice to doctors and patients for Tysabri (natalizumab) needed 20 Μάρτιος 2008Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use,17-19 March 2008 20 Μάρτιος 2008Press releaseHuman
Bioenvision Ltd withdraws its application for an extension of indication for Evoltra (clofarabine) 19 Μάρτιος 2008Press release
Neurochem withdraws its marketing authorisation application for Kiacta (eprodisate disodium) 17 Μάρτιος 2008Press release
Committee for medicinal products for veterinary use: Meeting of 11-13 March 2008 14 Μάρτιος 2008Press releaseVeterinary
Wyeth Europa Ltd withdraws its marketing authorisation application forPristiqs (desvenlafaxine) 12 Μάρτιος 2008Press release
EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines 10 Μάρτιος 2008Press releaseCorporate
Actelion withdraws its application for an extension of indication for Zavesca 25 Φεβρουάριος 2008Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008 21 Φεβρουάριος 2008Press releaseHuman